학술논문

A randomised phase II trial comparing docetaxel plus prednisone with docetaxel plus prednisone plus low-dose cyclophosphamide in castration-resistant prostate cancer
Document Type
Article
Source
In: Chemotherapy. (Chemotherapy, 24 March 2014, 60(2):129-134)
Subject
Language
English
ISSN
14219794
00093157